Abstract
Hematopoietic effects of human Herpesvirus-6 (HHV-6) infection following bone marrow transplantation (BMT) include delayed engraftment and early myelosuppression. Variant A has not been isolated after BMT. A case of graft failure is reported following an HLA-identical BMT for chronic myelogenous leukemia (CML) in chronic phase. Evaluation of bone marrow during the period of graft failure revealed variants A and B of HHV-6 by culture, immunofluorescence, polymerase chain reaction (PCR), and immunohistochemistry. Evidence for other cases of graft failure, including cytomegalovirus (CMV), could not be found. A hypothesis is proposed that late graft failure in this case was due to variant A of HHV-6.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 626-629 |
| Number of pages | 4 |
| Journal | Experimental Hematology |
| Volume | 23 |
| Issue number | 7 |
| State | Published - Jan 1 1995 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
All Science Journal Classification (ASJC) codes
- Molecular Biology
- Hematology
- Genetics
- Cell Biology
- Cancer Research
Fingerprint
Dive into the research topics of 'Late graft failure due to dual bone marrow infection with variants A and B of human Herpesvirus-6'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver